Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This randomized pilot phase I trial studies the side effects of donor bone marrow derived mesenchymal stem cells in controlling heart failure in patients with cardiomyopathy caused by anthracyclines. Donor bone marrow derived mesenchymal stem cells may help to control symptoms of heart failure and improve heart function.
Epistemonikos ID: e9c6001b04c1ab15d846144cd293e6dcea29fa36
First added on: May 17, 2024